Plaintiff in Columbine Lawsuit Dismisses Case Against Solvay Pharmaceuticals
Recently, injured Columbine student Mark Taylor dropped his claims against the maker of a prescription drug taken by one of the two gunmen, Eric Harris. "No money has been or will be paid to Mr. Taylor or his lawyers in exchange for this dismissal," Taylor and Solvay Pharmaceuticals said in a joint statement.
Harris and Dylan Klebold killed 12 students and a teacher at Columbine High School on April 20, 1999, before committing suicide. Taylor was one of at least 23 students who were wounded.
Taylor claimed that the drug Harris took, Luvox (a selective serotonin reuptake inhibitor), was a cause of the Columbine attack. Solvay contended that Harris exhibited dangerous behavior before taking the drug and stopped taking it before the attack.
WTO attorneys defending Solvay in this case before U.S. District Court for the District of Colorado were Mark. F. Kennedy, James E. Hooper, Jr., Amy L. Padden, and Andrew C.S. Efaw.